CBMA
Centro de Biologia Molecular e Ambiental
Centre of Molecular and Environmental Biology
![]() |
Paula Sampaio | |
... | |
253601546 | |
Assistant Professor/Researcher | |
Innovation for Life - Functional Genomics and Nanobiotechnology for Sustainable Living | |
Universidade do Minho - Campus de Gualtar, Departamento de Biologia - 4710-057, Braga - P |
Fungi have many precious talents: they decompose organic matter, are the source of antibiotics and play importante roles in the production of bread and beer, are vital symbiosis partners, and are exploited in many biotechnological applications. But there’s also a dark side: they are responsible for many devastating infections, not only in crop plants but also in animals, including humans. Candida yeasts are among the major fungal pathogens in humans. My main research areas are: 1- fungal diagnosis and identification: applying and developing new molecular techniques for the identification of human fungal pathogens and epidemiology studies. Were developed new microsatellite markers for differentiation of C. albicans and C. parapsilosis isolates (Sampaio et al. 2003, 2005, Sabino el al. 2010) and the differentiation of Sporothrix spp species (Oliveira et al. 2012). These and other markers have been used in the study of fungal epidemiology in Portugal (Correia et al. 2004, Sabino et al. 2010). From these studies we have identified and described a new fungal species, Candida bracarensis (Correia et al. 2006). Since Candida and Aspergillus species are the most frequently isolated fungal pathogens in Europe we have developed a new multiplex diagnostic method for the identification of the most clinically important species: C. albicans, C. parapsilosis, C. glabrata, C. krusei, C. tropicalis, A. fumigatus, A. flavus, A. terreus and A. niger.
2- microbial pathogenesis and host response: using in vitro cell cultures and in vivo of models to identify and study virulence factors and molecular mechanisms involved in host-fungus interaction. Microorganisms evolved mechanisms for increasing genetic variations in loci that are involved in critical interaction with the host. In Candida albicans one of those genes is CaRLM1. The role of CaRLM1, a putative transcription factor, was evaluated and we showed that CaRLM1 is required for C. albicans cell wall biogenesis and virulence (Delgado-Silva et al. 2014). Currently, we are determining the effect of different carbon sources in the expression of these genes and the consequent cell surface changes. In vivo and in vitro studies showed that adaptation not always involve trough increasing the virulence status. We showed a virulence decrease phenotype in Candida albicans variants of the same strain isolated from an immunocompromised patient with recurrent blood stream infection (Sampaio et al. 2010). Sequencing of these isolates are underway to evaluate genetic and genomic changes that may be associated with phenotypic heterogeneity responsible for the decreased virulence. 3- developing of a liposomal nanocarrier as a delivery system for immunoprotective strategies against Candida albicans infections More recently, we developed and Characterized a delivery systems based on cationic liposomes loaded with C. albicans cell wall surface antigenic proteins (Carneiro et al. 2015). We showed that Immunization of BALB/c mice with these DODAB:MO liposomes have a potent adjuvant effect and induced antibody and T lymphocyte responses towards associated antigens that protected mice against a lethal systemic infection (Carneiro et al. 2016). Heterologous expression of the proteins that induced protection is underway to develop a more efficient vaccine against Candida albicans as well as the determination if this system may also induce convergent immunity, conferring protection towards a non-target organism. |
|
|
“Biowaste derived volatile fatty acid platform for biopolymers, bioactive compounds and chemical building blocks – VOLATILE. H2020-NMBP-BIO-2016. Project number: 720777. Innovative green products and processes to promote Agri-Food BioEconomy - EcoAgriFood. N2020- NORTE-01-0145-FEDER-000009 |
|
Cetaceans as marine ecosystem health sentinels – CETSENSI (RECI/AAG-GLO/0470/2012). FCT financed project. Coordination: Catarina Eira, Universidade de Aveiro. Coordinator at the Universidade do Minho.
Biotransformation of by-products from fruit and vegetable processing industry into valuable bioproducts – TRANSBIO (Grant agreement no: 289603).Financed in the scope of the 7th framework programme EU, started on December 2011. Includes 16 participants, including laboratories, research centres and companies, from Spain, Portugal, Germany, Belgium, Italy, Romania, Argentina, Costa Rica and Mexico. Coordination: Thomas Dietrich from Fundacion Tecnalia Research & Innovation, Spain. Principal investigator of the portuguese team.
Mechanisms of Candida glabrata biofilms tolerance to antifungal agents (PTDC/SAU-MIC/119069/2010). Projeto financiado pela FCT, com início em 2012. Coordenação de Mariana Rangel Henriques, Universidade do Minho. Integra a equipa de investigação. Implementation of a Nacional Facility for DNA Microarrays: Phase II (PTDC/BIA-BCM/64745/2006). Rede iberoamericana de diagnóstico molecular de las micosis sistémicas y oportunistas. (Red 208RT0347 da CYTED). Immunobiological studies of Candida albicans recombinant secreted aspartic proteinases and their use as target antigens for vaccination against systemic candidiasis (POCI/SAU-IMI/58014/2004).
|
Carneiro C, Correia A, Collins T, Vilanova M, Pais C, Gomes AC, Real Oliveira ME, Sampaio P. 2015. DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. Eur J Pharm Biopharm. 89:190-200. doi: 10.1016/j.ejpb.2014.11.028.
V. Chillemi · C. Lo Passo · A. D. van Diepeningen · S. Rharmitt · D. Delfino · A. Cascio · N. E. Nnadi · B. D. Cilo · P. Sampaio · H.-J. Tietz · J. Pemán · G. Criseo · O. Romeo · F. Scordino. 2016. Multilocus microsatellite analysis of European and African Candida glabrata isolates. European Journal of Clinical. DOI 10.1007/s10096-016-2610-3.
J. Borges, D. Costa, E. Antunes, C. Lopes, M.S. Rodrigues, M. Apreutesei, E. Alves, N.P. Barradas, P. Pedrosa, C. Moura, L. Cunha, T. Polcar, F. Vaz, P. Sampaio. 2015.Biological behaviour of thin films consisting of Au nanoparticles dispersed in a TiO2 dielectric matrix. DOI:10.1016/j.vacuum.2015.03.036
Sabino R, Sampaio P, Rosado L, Videira Z, Grenouillet F, Pais C. 2015. Analysis of clinical and environmental Candida parapsilosis isolates by microsatellite genotyping-a tool for hospital infection surveillance. Clin Microbiol Infect. 21(10) doi: 10.1016/j.cmi.2015.06.001.
Sandra Mota · Rosana Alves · Catarina Carneiro · Sónia Silva · Alistair J Brown · Fabian Istel · Karl Kuchler · Paula Sampaio · Margarida Casal · Mariana Henriques · Sandra Paiva 2015· Candida glabrata susceptibility to antifungals and phagocytosis is modulated by acetate. Frontiers in Microbiology. 6:919
Irinyi et al. 2015. International Society of Human and Animal Mycology (ISHAM)-ITS reference DNA barcoding database - the quality controlled standard tool for routine identification of human and animal pathogenic fungi. Med Mycol. 53:313-37
Oliveira, Manoel; Franco-Duarte, Ricardo; Romeo, Orazio; Pais, Célia; Criseo, Giuseppe; Sampaio, Paula; Zancope-Oliveira, Rosely. 2015. Evaluation of T3B fingerprinting for identification of clinical and environmental Sporothrix species. FEMS Microbiol Lett. 362(6).
Joana Carvalho-Pereira, Catarina Vaz, Catarina Carneiro, Célia Pais, Paula Sampaio. 2015. Genetic Variability of Candida albicans Sap8 Propeptide in Isolates from Different Types of Infection. BioMed Research International 01/2015; 2015:1-8. DOI: 10.1155/2015/148343
Carneiro C, Correia A, Collins T, Vilanova M, Pais C, Gomes AC, Real Oliveira ME, Sampaio P. 2015. DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. Eur J Pharm Biopharm. 89:190-200, doi: 10.1016/j.ejpb.2014.11.028.
Barbedo LS, Vaz C, Pais C, Figueiredo-Carvalho MH, Muniz Mde M, Zancope-Oliveira RM, and Sampaio P. 2014. Different scenarios for Candida parapsilosis fungemia reveal high numbers of mixed C. parapsilosis and C. orthopsilosis infections. J Med Microbiol. 64:7-17, doi: 10.1099/jmm.0.080655-0. Catarina Carneiro, Catarina Vaz, Joana Carvalho-Pereira, Célia Pais, and Paula Sampaio. A new method for yeast phagocytosis analysis by flow cytometry. Journal of Microbiological Methods 101: 56-61 |
|||
Carneiro C, Correia A, Lima T, Vilanova M, Pais C, Gomes AC, Real Oliveira MECD, Sampaio P. DODAB: Monolein based liposomes as novel nanocarriers for vaccine design against Candida albicans infections. MEDICINE: 95 Nº10. Two Commerce Sq, 2001 Market st, Philadelphia, pa 19103 usa: Lippincott Williams & Wilkins, 2016. Sabino R, Rosado L, Sampaio P, and Pais C. 2009. Response to macrophage infection by Candida parapsilosis sensu stricto isolates with different multilocus genotypes. Mycoses; 52 (Suppl. 1): 106-107. |
|||
Alexandra Correia, Paula Sampaio, Manuel Vilanova, Célia Pais. 2016. Candida albicans: Clinical Relevance, Pathogenesis, and Host Immunity. Human Emerging and Re-emerging Infections: Viral and Parasitic Infections, Volume II. Pag. 929-952. John Wiley & Sons, Inc.
C Pais, R Franco-Duarte, P Sampaio, J Wildner, A Carolas, D Figueira, BS Ferreira. 2016 Production of Dicarboxylic Acid Platform Chemicals Using Yeasts: Focus on Succinic Acid- In: Biotransformation of Agricultural Waste and By-Products: The Food, Feed, Fibre, Fuel (4F) Economy (2016) Elsevier pp 237-269. Célia Pais and Paula Sampaio. 2014. Epidemiology of Invasive Candidiasis and Challenges for the Mycology Laboratory: Specificities of Candida glabrata. Current Clinical Microbiology Reports. Volume 1, Issue 1-2, pp 1-9. |
|||
|
|||
|
|||
|
PhD Joana Pereira com o tema "Development of a new antifungal strategy based on encapsulated antimicrobial peptides: evaluation of the mechanism of action and in vivo efficiency on Candida systemic infections" Bolseira FCT desde 2016. Catarina Carneiro sob o tema “Cationic Liposomes as antigenic delivery systems: development of an immunoprotective strategy against fungal infections”. Bolseira FCT. Terminou 2015 Co-supervisor of Manoel Marques Evangelista de Oliveira with the thesis title “Desenvolvimento de ferramentas moleculares para a diferenciação de espécies do complexo Sporothrix”. (finished 2013). PhD grant from CAPES, Brasil. Now he is a senior investigator at the Institute of Clinical Research Evandro Chagas, Fundação Oswaldo Cruz, Brasil.Terminou em 2014. Yolanda Bedsabé Delgado Silva sob o tema “Involvement of CaRLM1 in Candida albicans virulence”. Bolseira ALBAN terminou 2013. MCs Augusto Alexandre Costa Barbosa “Development of a novel recombinant subunit antigen as a vaccination target against candidiasis: Cht3 and Sap2 from Candida albicans” João Pacheco "The impact of carbon source in Candida albicans virulence: participation of RLM1 in pathogen host interaction" (Finished 2015) Catarina Vaz sob o tema “Characterization of Liposomes as Antigenic Delivery Systems: Evaluation of its Candidacidal Ability. (Finished 2012) Joana Pereira with the thesis title “Desenvolvimento de Biomarcadores para o Diagnóstico de Espécies Patogénicas de Candida spp” (finished 2012) Moisés Tavares with the thesis title "O papel do ar e água ambientais como veículos de transmissão de infecções fúngicas no Hospital Agostinho Neto, Cidade da Praia, Cabo Verde" (finished 2012). Ana Filipa Vale with the thesis title “Diversidade fúngica do guano em Portugal” (finished 2012) Julio César Chávez Galarza sob o tema “Phylogenetic Relationship of the most Common Pathogenic Candida Species Inferred by Sequence Analysis of Nuclear Genes”. Terminou 2009. Eugénia Sofia da Costa Nogueira sob o tema “Estudo da função do factor de transcrição rlm1 em Candida albicans”. Terminou em 2008. Marlene Elisabete Moreira dos Santos sob o tema “Virulence studies of Candida albicans recurrent isolates in a mouse model of disseminated infection”. Terminou 2008. Inês Cátia Dinis de Sousa sob o tema “Description and characterization of a microsatellite in Candida albicans IFF8 gene”. Terminou em 2007.
|